Migraine Drugs Industry - Regional Synopsis
On the basis of regional analysis, the migraine drugs market is segmented into five major region including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. North America industry is expected to dominate majority revenue share by 2037, due to increasing adoption of novel therapies and high prevalence of migraine.The Asia Pacific is projected to see significant growth in future on the account of rising demand for better healthcare services along with the contribution from the major developing economies such as India and China towards migraine drugs. Moreover, large undeserved patient population and high penetration from drug manufacturers is adding up to the key factors driving the growth of the market in the region over the forecast period.
